Aggarwal, Atul <br/><br/>
Soluble CD40 ligand is an early initiator of inflammation after coronary intervention.  [electronic resource] 

 -  Coronary artery disease  Dec 2004 
 - 471-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0954-6928 
<br/><br/><label>Standard No.: </label>10.1097/00019501-200412000-00003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Angioplasty, Balloon, Coronary<br/>Antibodies, Monoclonal--therapeutic use<br/>Biomarkers--blood<br/>C-Reactive Protein--metabolism<br/>CD40 Ligand--blood<br/>Coronary Disease--blood<br/>Enzyme-Linked Immunosorbent Assay<br/>Eptifibatide<br/>Female<br/>Humans<br/>Immunoglobulin Fab Fragments--therapeutic use<br/>Inflammation--blood<br/>Inflammation Mediators--blood<br/>Interleukin-1--blood<br/>Interleukin-6--blood<br/>Interleukins--blood<br/>Male<br/>Middle Aged<br/>Peptides--therapeutic use<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Postoperative Period<br/>Prospective Studies